Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weixing Guo

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Signal Transduction and Targeted Therapy|October 5, 2025
Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trialKang Wang, Jinkai Feng, Hongming Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2019
Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled StudyXubiao Wei, Yabo Jiang, Xiuping Zhang, et al.
Nature Cancer|February 5, 2022
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathwaysMin Li, Xuxiao He, Weixing Guo, et al.
Oncotarget|March 31, 2016
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statementShuqun Cheng, Jiamei Yang, Feng Shen, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2023
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinomaZhengqing Lei, Weihu Ma, Anfeng Si, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Signal Transduction and Targeted Therapy|October 5, 2025
Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trialKang Wang, Jinkai Feng, Hongming Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2019
Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled StudyXubiao Wei, Yabo Jiang, Xiuping Zhang, et al.
Nature Cancer|February 5, 2022
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathwaysMin Li, Xuxiao He, Weixing Guo, et al.
Oncotarget|March 31, 2016
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statementShuqun Cheng, Jiamei Yang, Feng Shen, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2023
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinomaZhengqing Lei, Weihu Ma, Anfeng Si, et al.
Pageof 4